One study showed that suppression of FGFR3 increased the expression of PD-L1 level via modulating its ubiquitination in bladder cancer cells, contributing to blockade of anticancer activity of CD8+ T cells (48). This evidence concerns the gene CD274 and urinary bladder carcinoma.